1-4 of 4
Dorothy H. Crawford
Close
Sort by
Journal Articles

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Clinical Trials & Observations
Tanzina Haque, Gwen M. Wilkie, Marie M. Jones, Craig D. Higgins, Gillian Urquhart, Phoebe Wingate, David Burns, Karen McAulay, Marc Turner, Christopher Bellamy, Peter L. Amlot, Deirdre Kelly, Alastair MacGilchrist, Maher K. Gandhi, Anthony J. Swerdlow, Dorothy H. Crawford
Journal: Blood
Blood (2007) 110 (4): 1123–1131.
https://doi.org/10.1182/blood-2006-12-063008
Published: 2007
Journal Articles

Epstein-Barr virus: the impact of scientific advances on clinical practice

Hilary Williams, Dorothy H. Crawford
Journal: Blood
Blood (2006) 107 (3): 862–869.
https://doi.org/10.1182/blood-2005-07-2702
Published: 2006
Journal Articles

Interferon γ (IFN-γ) polymorphism in posttransplantation lymphoproliferative disease

Ranjit V. Thomas, Karen McAulay, Craig Higgins, Gwen Wilkie, Dorothy H. Crawford
Journal: Blood
Blood (2005) 106 (4): 1502–1503.
https://doi.org/10.1182/blood-2005-03-1279
Published: 2005
Journal Articles

Success of Adoptive Immunotherapy Followed by Stem Cell Transplantation in the Management of Epstein Barr Virus (EBV)-Driven Primary Central Nervous System Lymphoma (PCNSL) in Immunodeficient Child.

Maged I. Gharib, MD, MRCP, MRCPath, Tanzina Haque, MB.BS, PhD, MRCPath, James A. Nicholson, MB.BS, MRCP, Gwen Wilkie, BSc., Marie Morton-Jones, BSc, Trevor F. Carr, PhD, Peter D. Arkwright, MB, D. Phil, Andrew J.L. Turner, MB.ChB, FRCPath, Anna M. Kelsey, FRCPath, Dorothy H. Crawford, MD, PhD, DSc, Robert F. Wynn, MD, MRCP, MRCPath
Journal: Blood
Blood (2004) 104 (11): 3115.
https://doi.org/10.1182/blood.V104.11.3115.3115
Published: 2004